Vylor (VYLR)

NYSEConsumer StaplesAgricultural InputsSnapshot 2026-11-04

$68.53-3.82%

Close 2026-11-05 · 1-day change

Investment OutlookAs of Nov 4, 2026

What could strengthen or challenge Vylor’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Nov 2, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

Matching fiscal periods, usable estimates and at least one analyst are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-31
Revenue	No revenue guidance available	1.89B
EPS	No EPS guidance available	0.11
Annual ending 2026-12-31
Revenue	No revenue guidance available	10.37B
EPS	No EPS guidance available	2.312
Annual ending 2027-12-31
Revenue	No revenue guidance available	10.77B
EPS	No EPS guidance available	2.61

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Execute $3B buyback	A supporting condition in Vylor's published investment case. The stated target is Complete $3B buyback.	Intact	Buyback is paused or reduced significantly	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain EPS growth to $2.61	A primary condition in Vylor's published investment case. The stated target is >= $2.61 EPS.	Intact	FY27 EPS falls below $2.61	Required source inputs unavailable Cannot calculate Diluted EPS from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Resolve state litigation	A supporting condition in Vylor's published investment case. The stated target is No adverse ruling.	Under Pressure	Court rules against the separation	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Sustain revenue growth to $10.8B	A primary condition in Vylor's published investment case. The stated target is >= $10.8B revenue.	Intact	FY27 revenue falls below $10.8B	Required source inputs unavailable Cannot calculate Revenue from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Nov 2, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · alphavantage

FY2027 EPS$2.61

$2.61 → $2.61 · observed estimates

FY2027 revenue$10.77B

$10.77B → $10.77B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · alphavantage
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-11-01	$2.61	$10,765,755,780	11 / 13
2026-11-02	$2.61	$10,765,755,780	11 / 13
2026-11-03	$2.61	$10,765,755,780	11 / 13
2026-11-04	$2.61	$10,765,755,780	11 / 13

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-09-01	5	1
2026-10-01	12	5
2026-11-01	11	5

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 11 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Oct 6–Nov 4 · 0 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Deutsche BankOct 14

$90.00New observation · no comparable prior

BNP ParibasOct 14

$75.00New observation · no comparable prior

UBSOct 12

$89.00New observation · no comparable prior

Goldman SachsOct 8

$87.00New observation · no comparable prior

OppenheimerOct 6

$82.00New observation · no comparable prior

$0$49.50$99.00

0 raises · 0 cuts · 0 unchanged · 5 without a comparable prior

How this is measured

Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Execute $3B buybackDirect metric needs a verified mapping
Maintain EPS growth to $2.61Required source inputs unavailable
Resolve state litigationPublished status: Under Pressure
Sustain revenue growth to $10.8BRequired source inputs unavailable

Next proof point

Nov 11, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

UnavailableTypical daily move · historical

Downside history

-7.6%Maximum drawdown · trailing year

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.